Overall survival · 1088 patients with early HCC
1 finding from 1 review
2‐year survival · 1088 patients with early HCC
1 finding from 1 review
Event‐free survival · 1088 patients with early HCC
1 finding from 1 review
Overall survival · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of people with ≥ 1 serious adverse events · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease progression · participants with unresectable hepatocellular carcinoma
It is very uncertain whether E1B‐deleted (dl1520) adenovirus changes proportion of people with disease progression compared with percutaneous ethanol injection (very low certainty).
1 finding from 1 review
Adverse events considered non‐serious · participants with unresectable hepatocellular carcinoma
It is very uncertain whether E1B‐deleted (dl1520) adenovirus changes adverse events considered non‐serious (number of participants) compared with percutaneous ethanol injection (very low certainty).
1 finding from 1 review
Intervention not reported
PEI versus PAI · hospitalised people with early HCC treated with PEI, PAI, or surgery.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Overall survival · hospitalised people with early HCC treated with PEI, PAI, or surgery.
1 finding from 1 review
no estimate extracted
185 participants
Low
Intervention not reported
Recurrence‐free survival · hospitalised people with early HCC treated with PEI, PAI, or surgery.
1 finding from 1 review
no estimate extracted
185 participants
Low
Intervention not reported
Number and type of adverse events · hospitalised people with early HCC treated with PEI, PAI, or surgery.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Duration of hospital stay · hospitalised people with early HCC treated with PEI, PAI, or surgery.
1 finding from 1 review
no estimate extracted
125 participants
Very low
Intervention not reported
Quality of life · hospitalised people with early HCC treated with PEI, PAI, or surgery.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
PEI versus surgery · hospitalised people with early HCC treated with PEI, PAI, or surgery.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality Total of deaths and the end of · acute bleeding gastric varices in people with portal hypertension
It is very uncertain whether cyanoacrylate changes mortality Total of deaths and the end of compared with band ligation (very low certainty).
1 finding from 1 review
Re‐bleeding Bleeding after initial success in the intervention · acute bleeding gastric varices in people with portal hypertension
It is very uncertain whether cyanoacrylate 1 mL changes re‐bleeding Bleeding after initial success in the intervention compared with cyanoacrylate 0.5 mL (very low certainty).
1 finding from 1 review
Control of bleeding Success in control the active variceal bleeding · acute bleeding gastric varices in people with portal hypertension
It is very uncertain whether cyanoacrylate 1 mL changes control of bleeding Success in control the active variceal bleeding compared with cyanoacrylate 0.5 mL (very low certainty).
1 finding from 1 review
Mortality Total deaths at 30 days · acute bleeding gastric varices in people with portal hypertension
It is very uncertain whether cyanoacrylate changes mortality Total deaths at 30 days compared with alcohol (very low certainty).
1 finding from 1 review
Failure of intervention · acute bleeding gastric varices in people with portal hypertension
It is very uncertain whether cyanoacrylate changes failure of intervention compared with alcohol (very low certainty).
1 finding from 1 review